110668-69-4

Basic information

• Product Name: 2-BROMO-1-(4-IMIDAZOL-1-YL-PHENYL)-ETHANONE
• Synonyms: 2-BROMO-1-(4-IMIDAZOL-1-YL-PHENYL)-ETHANONE;2-bromo-1-[4-(1h-imidazol-1-yl)phenyl]ethanone;2-Bromo-1-(5-bromo-2-methoxyphenyl)ethan-1-one;2-Bromo-4’-(imidazol-1-yl)acetophenone;1-(4-(1H-imidazol-1-yl)phenyl)-2-bromoethanone
• CAS NO: 110668-69-4
• Molecular Formula: C₁₁H₉BrN₂O
• Molecular Weight: 265.11
• Product Categories: Acetyl Halides;Phenyls & Phenyl-Het;Acetyl Halides;Phenyls & Phenyl-Het;Aromatics;Heterocycles;Aromatics, Heterocycles
• Mol File: 110668-69-4.mol

Chemical Properties

• Boiling Point: 405 °C at 760 mmHg
• Flash Point: 198.7 °C
• Appearance: /
• Density: 1.48 g/cm³
• Refractive Index: 1.632
• Storage Temp.: 2-8°C
• PKA: 4.97±0.10(Predicted)
• CAS DataBase Reference: 2-BROMO-1-(4-IMIDAZOL-1-YL-PHENYL)-ETHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-BROMO-1-(4-IMIDAZOL-1-YL-PHENYL)-ETHANONE(110668-69-4)
• EPA Substance Registry System: 2-BROMO-1-(4-IMIDAZOL-1-YL-PHENYL)-ETHANONE(110668-69-4)

Safety Data

• Hazardous Substances Data: 110668-69-4(Hazardous Substances Data)

Usage

Uses

An imidazole derivative as CB 1 receptor inverse agonist.

InChI:InChI=1/C11H9BrN2O/c12-7-11(15)9-1-3-10(4-2-9)14-6-5-13-8-14/h1-6,8H,7H2

Upstream product

• 10041-06-2 4'-(imidazol-1-yl)acetophenone 

Downstream Products

• 917904-46-2 C₂₈H₃₄N₄O₃ 
• 810662-97-6 [4-(4-imidazol-1-ylphenyl)oxazol-2-yl]-(4-methoxyphenyl)amine 

Relevant articles and documents

Investigation of anticancer potencies of newly generated Schiff base imidazolylphenylheterocyclic-2-ylmethylenethiazole-2-amines

A new series of multi-heterocyclic Schiff base was constructed starting from 4′-(imidazol-1-yl)-acetophenone which was converted to its 2-bromoethanone precursor which on cyclic condensation with thiourea yielded final thiazol-2-amine intermediate (3) to

Nucleus-independent chemical shift (NICS) as a criterion for the design of new antifungal benzofuranones

The assertion made by Wu et al. that aromaticity may have considerable implications for molecular design motivated us to use nucleus-independent chemical shifts (NICS) as an aromaticity criterion to evaluate the antifungal activity of two series of indol-4-ones. A linear regression analysis of NICS and antifungal activity showed that both tested variables were significantly related (p –1 for Candida glabrata, Candida krusei and Candida guilliermondii with compounds 15-32, 15-15 and 15-1. The MIC for filamentous fungi was 1.95 μg·mL–1 for Aspergillus niger for compounds 15-1, 15-33 and 15-34. The results obtained support the use of NICS in the molecular design of compounds with antifungal activity.

COMPOUDS AND USES THEREOF IN MODULATING AMYLOID BETA

Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors

A series of novel and potent 6-heteroaryl-pyrrolidino-tetrahydroisoquinolines with dual histamine H3 antagonist/serotonin transporter inhibitor activity is described. In vitro and in vivo data are discussed.